He Transitioned, Regretted It, and Faced the Truth About Autogynephilia - Ray (#9)
Ray spent eight years living as a transwoman before detransitioning and returning to life as a man. His conversation with the Beyond Gender hosts centres on autogynephilia — a concept that most European gender clinics have removed from their clinical vocabulary entirely. At a moment when Sweden, Finland and the Netherlands are reassessing medicalised gender treatment, Ray's testimony raises an uncomfortable but necessary question: how many transitions — adult as well as adolescent — are built on an incomplete clinical picture? His story is essential listening for European clinicians, policymakers and anyone navigating gender questions without easy answers.
Ray is a man who spent eight years living as a transwoman before choosing to detransition and return to life as a man. In this episode he speaks with unusual candour about the full arc of that journey — from childhood cross-dressing marked by shame and secrecy, through an encounter with trans identity via online communities, into medical transition and hormone therapy, and eventually back out again. He is not angry, and he is not a cautionary figure constructed to fit anyone's argument. He is simply honest about what he experienced and what he has concluded about himself. Central to that honesty is his willingness to name autogynephilia — the pattern of erotic and psychological attachment to a female self-image — as a genuine part of his inner life from an early age. This is a concept that has been largely removed from European clinical vocabulary. Gender clinics across Germany, the Netherlands, Belgium and Scandinavia have generally followed frameworks that discourage or bracket this category entirely, yet Ray describes how the pattern shaped his trajectory long before any clinical contact. For European clinicians now reviewing their assessment protocols — several are, in the wake of the Cass Review's influence spreading across the continent — his account raises questions that those frameworks were not designed to answer. Ray also describes how online spaces gave isolated, shame-burdened feelings a sudden language and a community. What had been a private struggle became, via internet forums and social media, a recognised identity with a clear medical pathway attached. This dynamic is increasingly documented in the research literature, and it is one that drove Sweden and Finland to restrict hormones for minors and prompted the Netherlands to re-examine its own historically influential protocol. That Ray's pathway involved adult transition does not make the pattern irrelevant — it suggests the same social mechanics operate across age groups. He is frank about the physical consequences of years of hormone therapy: complications that arose alongside whatever psychological relief the treatment provided at the time. The question of long-term risk and the adequacy of informed consent in gender medicine is now being actively debated by European regulators and ethics bodies. Ray's experience puts a face to those abstract discussions. Post-detransition, he describes not the disappearance of the feelings that drove him to transition but a different, more sustainable relationship with them — managed without medical intervention and without denial. That kind of nuanced outcome is almost entirely absent from European public discourse, and support services for people leaving transition remain scarce across the continent. His testimony is not a call to prevent anyone from transitioning. It is a case for honesty — about what autogynephilia is, about what online communities can accelerate, and about what full clinical assessment actually requires. That case is one that European clinicians, policymakers and individuals navigating gender questions all have reason to hear.
